---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-037568"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:54:05.697048+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biohaven expands at-the-market equity facility by $300M to total potential issuance

## Summary
- Amendment No. 1 increases existing ATM capacity by $300M in common shares; sales via J.P. Morgan as manager.
- New shares offered under effective shelf registration (333-274822) with prospectus supplement filed August 16, 2024.
- Sales depend on market conditions, share price, and capital needs; timing and amounts are at company's discretion.
- Original Equity Distribution Agreement dated October 2, 2023; prior capacity not disclosed in this filing.
- Proceeds from any sales will be used for general corporate purposes as determined by management.

## SEC filing metadata
- accession: 0001628280-24-037568
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000162828024037568/0001628280-24-037568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000162828024037568/bhvn-20240816.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-037568
- JSON: https://secwatch.observer/filing/0001628280-24-037568.json
- Plain text: https://secwatch.observer/filing/0001628280-24-037568.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.